Organon & Co.: Infertility trials

The registry lists 10 Infertility studies with Organon & Co. as lead sponsor. 0 are open to participants now and 5 have results posted.

Phase 1 1Phase 2 3Phase 3 4Phase 4 1No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Frozen-thawed Embryo Transfer (FTET) Cycle Follow-up Protocol (P06031)CompletedNCT01146418Phase 3Results posted
• Efficacy and Safety Study of a Single Injection of SCH 900962 Versus Daily recFSH Injections in Women Undergoing Controlled Ovarian Stimulation (Study P06029)CompletedNCT01144416Phase 3Results posted
• Predictive Factors for Ovarian Stimulation Using a Fixed Daily Dose of 200 IU Recombinant FSH (Study 142003)(P05696)CompletedNCT00778999Phase 4Results posted
• To Investigate Efficacy and Safety of a Single Injection of Org 36286 for Ovarian Stimulation Using Daily Recombinant FSH as Reference (Ensure)(P05690/MK-8962-001)CompletedNCT00702845Phase 3Results posted
• A Phase 2 Trial to Evaluate if Corifollitropin Alfa (Org 36286), Followed by a Low Daily Dose of hCG or Recombinant FSH Can Induce Monofollicular Growth in Women With WHO Group II Anovulatory Infertility (P05693)TerminatedNCT00697255Phase 2Results posted
• An Efficacy and Safety Study of Corifollitropin Alfa (MK-8962) in Contrast to Recombinant FSH for Use in Controlled Ovarian Stimulation of Indian Women (P07056, Also Known as MK-8962-029)WithdrawnNCT01599494Phase 3
• A Post Marketing Observational Study of the Safety and Efficacy of Elonva (Corifollitropin Alfa) in General Practice (P08165)CompletedNCT01408615
• Investigate Dose of Org 36286 to Initiate Multiple Follicular Growth in a Controlled Ovarian Hyperstimulation Protocol for IVF or IVF/ICSI (P07015)CompletedNCT00702806Phase 2
• Study to Investigate the Optimal Dose of Org 36286 to Induce Monofollicular Ovulation in Women With WHO Group II Anovulatory Infertility (P07016)CompletedNCT00702585Phase 2
• An Open-label, Single Center Trial to Assess the Pharmacokinetics, Pharmacodynamics and Safety of Org 36286 (P07004)CompletedNCT00647933Phase 1